ChristopherETouloukianMD
General Surgery • Indianapolis, INAssociate Professor, Surgery, Indiana University School of Medicine
Are you Dr. Touloukian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 116 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
545 Barnhill Dr Eh 5th Floor
University Surgeons Inc
Indianapolis, IN 46202Phone+1 317-274-4122Fax+1 317-274-0241
Summary
- Dr. Christopher Touloukian, MD is a general surgeon in Indianapolis, Indiana. He is currently licensed to practice medicine in Indiana, Massachusetts, and Connecticut. He is affiliated with NYC Health + Hospitals / Queens and is an Associate Professor at Indiana University School of Medicine.
Education & Training
Duke University HospitalResidency, Surgery, 2001 - 2004
Yale-New Haven Medical CenterResidency, Surgery, 1994 - 2000
Columbia University Vagelos College of Physicians and SurgeonsClass of 1994
Certifications & Licensure
NY State Medical License 2014 - 2026
MA State Medical License 2017 - 2025
CT State Medical License 2016 - 2017
IN State Medical License 2004 - 2017
NC State Medical License 2001 - 2004- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 35 citationsChemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating FactorRavi P. Sahu, Jesus A. Ocana, Kathleen A. Harrison, Matheus Ferracini, Christopher E. Touloukian
Cancer Research. 2014-12-01 - 6 citationsImpaired PIASy-Tip60 signaling weakens activation of p53 in melanoma.Alexander J. Lakhter, Sriramana Kanginakudru, Simon Warren, Christopher E. Touloukian, Raymond E. Boissy
Melanoma Research. 2013-06-01 - 51 citationsThe environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonistsRavi P. Sahu, Matthew J. Turner, Sonia C. DaSilva, Badri Rashid, Jesus A. Ocana
Carcinogenesis. 2012-07-01
Press Mentions
New Doctor Joins Expanded Berkshire Surgical Services of BMCJune 5th, 2017
Grant Support
- Durable CD4+ T-Cell Tumor Immunity Following Gene-Modified HpscNational Cancer Institute2009–2012
Professional Memberships
- Member
